Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3084) 3084
Publication (471) 471
Book / eBook (220) 220
Book Review (41) 41
Book Chapter (7) 7
Dissertation (4) 4
Data Set (3) 3
Conference Proceeding (2) 2
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2643) 2643
male (2032) 2032
index medicus (1830) 1830
urologic and male genital diseases (1438) 1438
middle aged (1415) 1415
aged (1409) 1409
female (1405) 1405
cancer (1054) 1054
oncology (1037) 1037
adult (804) 804
urology & nephrology (796) 796
prognosis (645) 645
aged, 80 and over (633) 633
prostate cancer (612) 612
urology (588) 588
retrospective studies (492) 492
urologic neoplasms - mortality (478) 478
risk factors (471) 471
treatment outcome (451) 451
care and treatment (448) 448
survival (432) 432
tumors (414) 414
mortality (411) 411
female genital diseases and pregnancy complications (410) 410
urologic neoplasms - pathology (410) 410
surgery (408) 408
research (405) 405
carcinoma (393) 393
metastasis (392) 392
diagnosis (365) 365
urologic neoplasms - surgery (337) 337
analysis (330) 330
neoplasm staging (327) 327
health aspects (323) 323
medicine (309) 309
chemotherapy (304) 304
research article (286) 286
survival rate (282) 282
neoplasms (277) 277
urothelial carcinoma (269) 269
bladder cancer (264) 264
prostatic neoplasms - pathology (261) 261
follow-up studies (258) 258
animals (255) 255
article (253) 253
bladder-cancer (252) 252
disease-free survival (242) 242
survival analysis (240) 240
urologic diseases (237) 237
risk (230) 230
expression (226) 226
transitional-cell carcinoma (221) 221
patients (215) 215
prostate (214) 214
kaplan-meier estimate (211) 211
cell line, tumor (210) 210
urogenital system (210) 210
pathology (209) 209
time factors (203) 203
kidney neoplasms - pathology (197) 197
carcinoma, transitional cell - mortality (195) 195
bladder (194) 194
medicine & public health (194) 194
studies (192) 192
development and progression (191) 191
urologic neoplasms - drug therapy (191) 191
renal cell carcinoma (189) 189
gene expression (188) 188
therapy (186) 186
disease progression (174) 174
carcinoma, transitional cell - pathology (172) 172
medical prognosis (172) 172
neoplasms. tumors. oncology. including cancer and carcinogens (172) 172
multidisciplinary sciences (170) 170
multivariate analysis (170) 170
proportional hazards models (169) 169
incidence (166) 166
genetic aspects (165) 165
prostatic neoplasms - diagnosis (165) 165
carcinoma, transitional cell - surgery (163) 163
original (159) 159
urologic neoplasms - diagnosis (155) 155
antineoplastic combined chemotherapy protocols - therapeutic use (154) 154
diseases (153) 153
nephrectomy (153) 153
urinary bladder neoplasms - pathology (152) 152
patient outcomes (151) 151
outcomes (150) 150
urothelium - pathology (150) 150
apoptosis (149) 149
biopsy (149) 149
biomarkers (148) 148
immunohistochemistry (147) 147
recurrence (147) 147
carcinoma, renal cell (146) 146
cancer therapies (145) 145
men (145) 145
kidney neoplasms - mortality (144) 144
medical research (143) 143
neoplasm metastasis (143) 143
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (192) 192
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Scarborough Hospital - General (7) 7
Holland Bloorview Kids Rehabilitation - Stacks (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Credit Valley Hospital - Stacks (3) 3
Humber River Regional Hospital - Church Stacks (3) 3
Scarborough Hospital - Birchmount (3) 3
St. Michael's Hospital - Stacks (3) 3
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Online Resources - Online (2) 2
Providence Healthcare - Reference (2) 2
Toronto East General Hospital - Stacks (2) 2
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Not Returned (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Providence Healthcare - Reserve desk (1) 1
St Josephs Health Centre - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3174) 3174
German (41) 41
French (33) 33
Japanese (25) 25
Spanish (13) 13
Turkish (10) 10
Russian (9) 9
Bulgarian (3) 3
Italian (3) 3
Polish (3) 3
Arabic (2) 2
Danish (2) 2
Dutch (2) 2
Chinese (1) 1
Czech (1) 1
Hebrew (1) 1
Hungarian (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text EUROCARE-3: Survival of cancer patients diagnosed 1990-94 - Results and commentary
by Sant, M and Aareleid, T and Berrino, F and Bielska Lasota, M and Carli, P.M and Faivre, J and Grosclaude, P and Hédelin, G and Matsuda, T and Møller, H and Möller, T and Verdecchia, A and Capocaccia, R and Gatta, G and Micheli, A and Santaquilani, M and Roazzi, P and Lisi, D and Oberaigner, W and Jechova, M and Rousarova, M and Storm, H.H and Aareleid, T and Hakulinen, T and Hédelin, G and Tron, I and Le Gall, E and Launoy, G and Macé-Lesech, J and Faivre, J and Chaplain, G and Carli, P.-M and Danzon, A and Tretarre, B and Colonna, M and Lacour, B and Raverdy, N and Berger, C and Freycon, F and Grosclaude, P and Estève, J and Kaatsch, P and Ziegler, H and Hölzel, D and Schubert Fritschle, G and Tryggvadottir, L and Berrino, F and Allemani, C and Baili, P and Ciccolallo, L and Gatta, G and Micheli, A and Sant, M and Taussig, E and Capocaccia, R and Carrani, E and De Angelis, R and Hartley, S and Roazzi, P and Santaquilani, M and Tavilla, A and Valente, F and Verdecchia, A and Ferretti, S and Crosignani, P and Contiero, P and Conti, E and Vercelli, M and Pannelli, F and Vitarelli, S and Pannelli, F and Mosciatti, P and Federico, M and Artioli, M.E and Ponz De Leon, M and Benatti, P and De Lisi, V and Serventi, L and Zanetti, R and Patriarca, S and Magnani, C and Pastore, G and Gafà, L and Tumino, R and Falcini, F and Budroni, M and Paci, E and Crocetti, E and Zambon, P and Guzzinati, S and Dalmas, M and Langmark, F and Andersen, A and Rachtan, J and Bielska Lasota, M and Wronkowski, Z and Zwierko, M and Pinheiro, P.S and Pleško, I and Obsitníková, A and ... and EUROCARE Working Grp and EUROCARE Working Group
Annals of Oncology, ISSN 0923-7534, 12/2003, Volume 14, Issue 5, pp. v61 - v118
EUROCARE-3 analysed the survival of 1815584 adult cancer patients diagnosed from 1990 to 1994 in 22 European countries. The results are reported in tables, one... 
Cancer survival | Europe | Population-based cancer registries | Age-standardised relative survival | International comparison | ONCOLOGY | international comparison | population-based cancer registries | age-standardised relative survival | cancer survival | Urologic Neoplasms - epidemiology | Testicular Neoplasms - mortality | Digestive System Neoplasms - mortality | Lung Neoplasms - mortality | Hematologic Neoplasms - mortality | Humans | Thyroid Neoplasms - epidemiology | Male | Neoplasms - diagnosis | Testicular Neoplasms - epidemiology | Hematologic Neoplasms - epidemiology | Genital Neoplasms, Female - epidemiology | Registries - statistics & numerical data | Skin Neoplasms - mortality | Head and Neck Neoplasms - epidemiology | Female | Brain Neoplasms - mortality | Breast Neoplasms - epidemiology | Digestive System Neoplasms - epidemiology | Thyroid Neoplasms - mortality | Urologic Neoplasms - mortality | Europe - epidemiology | Neoplasms - mortality | Survival Rate | Skin Neoplasms - epidemiology | Prostatic Neoplasms - mortality | Prostatic Neoplasms - epidemiology | Genital Neoplasms, Female - mortality | Lung Neoplasms - epidemiology | Sex Factors | Survival Analysis | Breast Neoplasms - mortality | Head and Neck Neoplasms - mortality | Neoplasms - epidemiology | Brain Neoplasms - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Visceral Disease in Castration-resistant Prostate Cancer
by Pezaro, Carmel J and Omlin, Aurelius and Lorente, David and Nava Rodrigues, Daniel and Ferraldeschi, Roberta and Bianchini, Diletta and Mukherji, Deborah and Riisnaes, Ruth and Altavilla, Amelia and Crespo, Mateus and Tunariu, Nina and de Bono, Johann S and Attard, Gerhardt
European Urology, ISSN 0302-2838, 2013, Volume 65, Issue 2, pp. 270 - 273
Abstract Metastatic involvement of the viscera in men with advanced castration-resistant prostate cancer (CRPC) has been poorly characterised to date. In 359... 
Urology | Castration-resistant prostate cancer | SURVIVAL | TRIAL | Visceral metastases | UROLOGY & NEPHROLOGY | Bone Neoplasms - mortality | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Bone Neoplasms - secondary | Male | Tomography, X-Ray Computed | Antineoplastic Agents - therapeutic use | Liver Neoplasms - mortality | Prostatic Neoplasms, Castration-Resistant - pathology | Liver Neoplasms - blood | Lung Neoplasms - secondary | Time Factors | Kallikreins - blood | Bone Neoplasms - drug therapy | Bone Neoplasms - blood | Liver Neoplasms - secondary | Bone Neoplasms - diagnostic imaging | Prostatic Neoplasms, Castration-Resistant - blood | Risk Factors | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Proportional Hazards Models | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Liver Neoplasms - diagnostic imaging | Prostate-Specific Antigen - blood | Phenotype | Lung Neoplasms - diagnostic imaging | Lung Neoplasms - blood | Prostatic Neoplasms, Castration-Resistant - mortality | Prostatic Neoplasms, Castration-Resistant - diagnostic imaging | Liver cancer | Prostate cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Urologic cancer in China
by Pang, Cheng and Guan, Youyan and Li, Hongbo and Chen, Wanqing and Zhu, Gang
Japanese Journal of Clinical Oncology, ISSN 0368-2811, 06/2016, Volume 46, Issue 6, pp. 497 - 501
Cancer remains to be the second most common cause of death, and its incidence and mortality rates are increasing in China. According to the 2015 National... 
Treatment | Diagnosis | Bladder cancer | Kidney cancer | Prostrate cancer | kidney cancer | MORTALITY | treatment | prostrate cancer | ONCOLOGY | bladder cancer | diagnosis | RADICAL PROSTATECTOMY | OUTCOMES | METASTATIC PROSTATE-CANCER | Carcinoma, Transitional Cell - mortality | Penile Neoplasms - diagnosis | Testicular Neoplasms - mortality | Kidney Neoplasms - epidemiology | Urologic Neoplasms - diagnosis | Carcinoma, Transitional Cell - epidemiology | Urinary Bladder Neoplasms - diagnosis | Humans | Male | Testicular Neoplasms - epidemiology | Prostatic Neoplasms - diagnosis | Kidney Neoplasms - diagnosis | Penile Neoplasms - epidemiology | Urologic Neoplasms - pathology | China | Urinary Bladder Neoplasms - pathology | Urinary Bladder Neoplasms - epidemiology | Penile Neoplasms - mortality | Prostatic Neoplasms - pathology | Testicular Neoplasms - diagnosis | Urinary Bladder Neoplasms - mortality | Carcinoma, Renal Cell - pathology | Carcinoma, Transitional Cell - diagnosis | Kidney Neoplasms - mortality | Prostatic Neoplasms - mortality | Prostatic Neoplasms - epidemiology | Carcinoma, Renal Cell - mortality | Carcinoma, Renal Cell - epidemiology | Carcinoma, Transitional Cell - pathology | Carcinoma, Renal Cell - diagnosis | Kidney Neoplasms - pathology | Urologic Neoplasms - surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
by Heng, Daniel Y.C and Wells, J. Connor and Rini, Brian I and Beuselinck, Benoit and Lee, Jae-Lyun and Knox, Jennifer J and Bjarnason, Georg A and Pal, Sumanta Kumar and Kollmannsberger, Christian K and Yuasa, Takeshi and Srinivas, Sandy and Donskov, Frede and Bamias, Aristotelis and Wood, Lori A and Ernst, D. Scott and Agarwal, Neeraj and Vaishampayan, Ulka N and Rha, Sun Young and Kim, Jenny J and Choueiri, Toni K
European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 4, pp. 704 - 710
Abstract Background The benefit of cytoreductive nephrectomy (CN) for overall survival (OS) is unclear in patients with synchronous metastatic renal cell... 
Urology | Metastatic renal cell carcinoma | Targeted therapy | Cytoreductive nephrectomy | SURVIVAL | INTERFERON-ALPHA | VALIDATION | SUNITINIB | UROLOGY & NEPHROLOGY | MODEL | Neoplasms, Multiple Primary - surgery | Confidence Intervals | Cytoreduction Surgical Procedures - mortality | Follow-Up Studies | Humans | Middle Aged | Carcinoma, Renal Cell - surgery | Male | Antineoplastic Agents - therapeutic use | Nephrectomy - methods | Kidney Neoplasms - surgery | Female | Retrospective Studies | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Molecular Targeted Therapy - methods | Databases, Factual | Neoplasms, Multiple Primary - mortality | Risk Assessment | Carcinoma, Renal Cell - pathology | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Cytoreduction Surgical Procedures - methods | Nephrectomy - mortality | Kidney Neoplasms - mortality | Neoplasms, Multiple Primary - pathology | Carcinoma, Renal Cell - mortality | Disease-Free Survival | Survival Analysis | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy | Neoplasms, Multiple Primary - drug therapy | Hospitals | Metastasis | Carcinoma, Renal cell
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Global Burden of Urologic Cancers, 1990–2013
by Dy, Geolani W and Gore, John L and Forouzanfar, Mohammad H and Naghavi, Mohsen and Fitzmaurice, Christina
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 3, pp. 437 - 446
Abstract Context Kidney, prostate, and bladder cancers increase with age and are influenced partly by modifiable risk factors. Urological cancer rates may... 
Urology | Trends | Bladder cancer | Prostate cancer | Mortality | Kidney cancer | Incidence | SURGERY | COUNTRIES | TIME | UROLOGY & NEPHROLOGY | INTERNATIONAL VARIATIONS | INDEX | EPIDEMIOLOGY | Urologic Neoplasms - epidemiology | Urinary Bladder Neoplasms - mortality | Age Distribution | Kidney Neoplasms - epidemiology | Humans | Risk Factors | Male | Kidney Neoplasms - mortality | Prostatic Neoplasms - mortality | Prostatic Neoplasms - epidemiology | Developed Countries | Global Burden of Disease - trends | Obesity - epidemiology | Sex Distribution | Female | Developing Countries | Urinary Bladder Neoplasms - epidemiology | Cancer | Developing countries | Analysis | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Predicting Clinical Outcomes After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
by Cha, Eugene K and Shariat, Shahrokh F and Kormaksson, Matthias and Novara, Giacomo and Chromecki, Thomas F and Scherr, Douglas S and Lotan, Yair and Raman, Jay D and Kassouf, Wassim and Zigeuner, Richard and Remzi, Mesut and Bensalah, Karim and Weizer, Alon and Kikuchi, Eiji and Bolenz, Christian and Roscigno, Marco and Koppie, Theresa M and Ng, Casey K and Fritsche, Hans-Martin and Matsumoto, Kazumasa and Walton, Thomas J and Ehdaie, Behfar and Tritschler, Stefan and Fajkovic, Harun and Martínez-Salamanca, Juan I and Pycha, Armin and Langner, Cord and Ficarra, Vincenzo and Patard, Jean-Jacques and Montorsi, Francesco and Wood, Christopher G and Karakiewicz, Pierre I and Margulis, Vitaly
European Urology, ISSN 0302-2838, 2012, Volume 61, Issue 4, pp. 818 - 825
Abstract Background Novel prognostic factors for patients after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) have recently been... 
Urology | Upper urinary tract | Survival prediction | Nephroureterectomy | Urothelial carcinoma | Nomogram | BLADDER-CANCER | IMPACT | UPPER URINARY-TRACT | PROGNOSTIC MODELS | UROLOGY & NEPHROLOGY | CANCER-SPECIFIC SURVIVAL | Multivariate Analysis | Humans | Middle Aged | Ureteral Neoplasms - pathology | Carcinoma - mortality | Male | North America | Urothelium - pathology | Urologic Neoplasms - pathology | Nephrectomy | Time Factors | Female | Retrospective Studies | Carcinoma - secondary | Urologic Surgical Procedures | Risk Assessment | Urologic Neoplasms - mortality | Carcinoma - surgery | Europe | Risk Factors | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Proportional Hazards Models | Treatment Outcome | Lymphatic Metastasis | Ureter - surgery | Disease-Free Survival | Aged | Ureteral Neoplasms - mortality | Urothelium - surgery | Ureter - pathology | Ureteral Neoplasms - surgery | Urologic Neoplasms - surgery | Medical colleges | Carcinoma | Prognosis | Patient outcomes | Biometry | Cancer | Bioengineering | Life Sciences | Ureteral Neoplasms | Ureter | Human health and pathology | Urologic Neoplasms | Urology and Nephrology | Urothelium
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with gleason score 9-10 prostate cancer
by Kishan, Amar U and Cook, Ryan R and Ciezki, Jay P and Ross, Ashley E and Pomerantz, Mark M and Nguyen, Paul L and Shaikh, Talha and Tran, Phuoc T and Sandler, Kiri A and Stock, Richard G and Merrick, Gregory S and Demanes, D. Jeffrey and Spratt, Daniel E and Abu-Isa, Eyad I and Wedde, Trude B and Lilleby, Wolfgang and Krauss, Daniel J and Shaw, Grace K and Alam, Ridwan and Reddy, Chandana A and Stephenson, Andrew J and Klein, Eric A and Song, Daniel Y and Tosoian, Jeffrey J and Hegde, John V and Yoo, Sun Mi and Fiano, Ryan and D’Amico, Anthony V and Nickols, Nicholas G and Aronson, William J and Sadeghi, Ahmad and Greco, Stephen and Deville, Curtiland and McNutt, Todd and DeWeese, Theodore L and Reiter, Robert E and Said, Johnathan W and Steinberg, Michael L and Horwitz, Eric M and Kupelian, Patrick A and King, Christopher R
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 03/2018, Volume 319, Issue 9, pp. 896 - 905
IMPORTANCE The optimal treatment for Gleason score 9-10 prostate cancer is unknown. OBJECTIVE To compare clinical outcomes of patients with Gleason score 9-10... 
ANDROGEN SUPPRESSION | SURVIVAL | SURGERY | GRADING SYSTEM | MEDICINE, GENERAL & INTERNAL | REPORTED OUTCOMES | MEN | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | ASCENDE-RT | RADIATION-THERAPY | Prostatic Neoplasms - pathology | Follow-Up Studies | Humans | Middle Aged | Male | Combined Modality Therapy | Cause of Death | Disease Progression | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Propensity Score | Neoplasm Metastasis | Neoplasm Grading | Radiotherapy - methods | Survival Analysis | Aged, 80 and over | Androgen Antagonists - therapeutic use | Adult | Prostatectomy | Aged | Brachytherapy | Retrospective Studies | Neoplasm Staging | Treatment outcome | Usage | Care and treatment | Radioisotope brachytherapy | Analysis | Diagnosis | Prostate cancer | Deprivation | Adjustment | Mortality | Medical services | Oncology | Radiation therapy | Patients | Survival | Urology | Metastases | Androgens | Prostate | Cancer | Original Investigation | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Comparative risk‐adjusted mortality outcomes after primary surgery, radiotherapy, or androgen‐deprivation therapy for localized prostate cancer
by Cooperberg, Matthew R and Vickers, Andrew J and Broering, Jeanette M and Carroll, Peter R and Canc Prostate Strategic Urologic and for the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Investigators
Cancer, ISSN 0008-543X, 11/2010, Volume 116, Issue 22, pp. 5226 - 5234
BACKGROUND: Because no adequate randomized trials have compared active treatment modalities for localized prostate cancer, the authors analyzed risk‐adjusted,... 
comparative effectiveness | hormone therapy | prostate neoplasms | radiation | Cancer of the Prostate Strategic Urologic Research Endeavor | surgery | BIOCHEMICAL RECURRENCE | PREOPERATIVE NOMOGRAM | RADICAL PROSTATECTOMY | RANDOMIZED CONTROLLED-TRIAL | RADIATION-THERAPY | PHASE-III TRIAL | ASSESSMENT SCORE | ONCOLOGY | RESEARCH ENDEAVOR CAPSURE | UNIVERSITY-OF-CALIFORNIA | DISEASE RECURRENCE | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Androgen Antagonists - therapeutic use | Male | Prostatectomy | Risk | Treatment Outcome | Aged | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Care and treatment | Usage | Hormone therapy | Patient outcomes | Antiandrogens | Radiotherapy | Prostate cancer | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival
by Bourgade, Vincent and Drouin, Sarah J and Yates, David R and Parra, Jerôme and Bitker, Marc-Olivier and Cussenot, Olivier and Rouprêt, Morgan
World Journal of Urology, ISSN 0724-4983, 4/2014, Volume 32, Issue 2, pp. 475 - 479
Our aim was to assess the effect of surgical wait time on the survival of patients with urological neoplasms, including prostate, bladder, penile, and... 
Nephrology | Medicine & Public Health | Urology/Andrology | Renal cell carcinoma | Surgery | Oncology | Urothelial carcinoma | Waiting time | Survival | Prostate cancer | BLADDER-CANCER | SMALL RENAL MASSES | MANAGEMENT | RADICAL PROSTATECTOMY | SURVEILLANCE | UROLOGY & NEPHROLOGY | CYSTECTOMY | QUALITY-OF-LIFE | DELAY | Carcinoma, Transitional Cell - mortality | Penile Neoplasms - diagnosis | Prostatectomy - methods | Testicular Neoplasms - mortality | Urologic Neoplasms - diagnosis | Urinary Bladder Neoplasms - diagnosis | Humans | Carcinoma, Renal Cell - surgery | Male | Prostatic Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - diagnosis | Nephrectomy - methods | Kidney Neoplasms - diagnosis | Testicular Neoplasms - surgery | Kidney Neoplasms - surgery | Time Factors | Neoplasms, Germ Cell and Embryonal - mortality | Penile Neoplasms - mortality | Testicular Neoplasms - diagnosis | Urinary Bladder Neoplasms - mortality | Prostatic Neoplasms - surgery | Time-to-Treatment | Urologic Neoplasms - mortality | Carcinoma, Transitional Cell - diagnosis | Kidney Neoplasms - mortality | Urinary Bladder Neoplasms - surgery | Prostatic Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Penile Neoplasms - surgery | Carcinoma, Renal Cell - diagnosis | Ureteral Neoplasms - diagnosis | Neoplasms, Germ Cell and Embryonal - surgery | Carcinoma, Transitional Cell - surgery | Ureteral Neoplasms - mortality | Ureteral Neoplasms - surgery | Cystectomy - methods | Orchiectomy - methods | Urologic Neoplasms - surgery | Diagnosis | Health aspects | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Prognostic Significance of Lymphovascular Invasion in Upper Urinary Tract Urothelial Carcinoma is Influenced by Tumor Location
by Lee, Hsiang-Ying and Li, Ching-Chia and Huang, Chun-Nung and Ke, Hung-Lung and Li, Wei-Ming and Liang, Peir-In and Yang, Sheau-Fang and Tu, Hung-Pin and Wu, Wen-Jeng and Yeh, Hsin-Chih
Annals of Surgical Oncology, ISSN 1068-9265, 03/2015, Volume 22, Issue 4, pp. 1392 - 1400
To examine the prognostic value of lymphovascular invasion (LVI) in different tumor locations (i.e., renal pelvis and ureter) of upper urinary tract urothelial... 
RADICAL NEPHROURETERECTOMY | SURVIVAL | SURGERY | IMPACT | RENAL PELVIS | MULTIFOCALITY | SERIES | ONCOLOGY | RECURRENCE | ONCOLOGICAL OUTCOMES | CANCER | PREDICTIVE FACTORS | Lymph Nodes - pathology | Prognosis | Follow-Up Studies | Lymph Nodes - surgery | Humans | Pelvic Neoplasms - mortality | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Neoplasm Recurrence, Local - pathology | Kidney Neoplasms - surgery | Urologic Neoplasms - pathology | Neoplasm Grading | Nephrectomy | Vascular Neoplasms - mortality | Vascular Neoplasms - pathology | Female | Retrospective Studies | Pelvic Neoplasms - pathology | Vascular Neoplasms - surgery | Pelvic Neoplasms - surgery | Neoplasm Invasiveness | Urologic Neoplasms - mortality | Survival Rate | Lymphatic Metastasis | Kidney Neoplasms - mortality | Ureter - surgery | Kidney Neoplasms - pathology | Aged | Neoplasm Staging | Ureter - pathology | Urologic Neoplasms - surgery | Medical colleges | Carcinoma | Analysis | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
by Donovan, Jenny L and Hamdy, Freddie C and Lane, J. Athene and Mason, Malcolm and Metcalfe, Chris and Walsh, Eleanor and Blazeby, Jane M and Peters, Tim J and Holding, Peter and Bonnington, Susan and Lennon, Teresa and Bradshaw, Lynne and Cooper, Deborah and Herbert, Phillipa and Howson, Joanne and Jones, Amanda and Lyons, Norma and Salter, Elizabeth and Thompson, Pauline and Tidball, Sarah and Blaikie, Jan and Gray, Catherine and Bollina, Prasad and Catto, James and Doble, Andrew and Doherty, Alan and Gillatt, David and Kockelbergh, Roger and Kynaston, Howard and Paul, Alan and Powell, Philip and Prescott, Stephen and Rosario, Derek J and Rowe, Edward and Davis, Michael and Turner, Emma L and Martin, Richard M and Neal, David E and ProtecT Study Grp and ProtecT Study Group
The New England Journal of Medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 15, pp. 1425 - 1437
The choice of treatment for PSA-detected, localized prostate cancer is influenced by effects of the interventions on quality of life. In the ProtecT trial,... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | ACTIVE SURVEILLANCE | MEN | VALIDATION | RADICAL PROSTATECTOMY | QUALITY-OF-LIFE | RANDOMIZED CONTROLLED-TRIAL | INTERVENTION | URINARY-INCONTINENCE | Erectile Dysfunction | Prostatic Neoplasms - radiotherapy | Outcome Assessment (Health Care) | Prostatic Neoplasms - surgery | Humans | Middle Aged | Digestive System Diseases | Male | Treatment Outcome | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Intention to Treat Analysis | Quality of Life | Urologic Diseases | Prostatectomy | Surveys and Questionnaires | Watchful Waiting | Aged | Health Status | Care and treatment | Usage | Patient outcomes | Surgery | Analysis | Research | Radiotherapy | Prostate cancer | Patients | Health aspects | Quality of life | Clinical trials | Data processing | Radiation therapy | Mental depression | Clinical outcomes | Cancer surgery | Motivation | Intestine | Comparative studies | Anxiety | Prostate
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights